John C. Wallenburg, PhD, PhD

Chief Scientific Officer
Cystic Fibrosis Canada, Canada

Poster(s):

• (37) Trends in Canadian cystic fibrosis healthcare utilization amidst the COVID-19 pandemic
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (51) Outcomes following SARS-CoV-2 infection among Canadians living with cystic fibrosis: Analyses using the Canadian Cystic Fibrosis Registry
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (367) Measuring Burden of Disease for Canadians, both Adult and Pediatric, with Cystic Fibrosis (CF) and their Caregivers - A Systematic Literature Review
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET